The world's largest provider of Autologous Precursor Stem Cells
The world's largest provider of Autologous Precursor Stem Cells
Stability | Somewhat stable | unstable due to oncogenicity |
Treatment used | > 70 years and about 1 million patients treated with sufficient data | < 70 years |
Attainability | Easy and safe in natural environment | Exist only in a laboratory dish and not in a living embryo |
Origin | Abundantly available | Rare |
Renewal | Long term self renewal | Self renewal except in cancer cases |
Method of Preparation | Based on primary tissue culture of tissue fragments or cell clusters | Based on primary cell culture of dispersed cells. |